Jonathan Zalevsky, the Chief R&D Officer of $NKTR, sold 180 shares of the company on 02-18-2026 for an estimated $13,140. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.8% of their shares of this class of stock. Following this trade, they now own 21,174 shares of this class of $NKTR stock.
$NKTR Insider Trading Activity
$NKTR insiders have traded $NKTR stock on the open market 23 times in the past 6 months. Of those trades, 0 have been purchases and 23 have been sales.
Here’s a breakdown of recent trading of $NKTR stock by insiders over the last 6 months:
- HOWARD W ROBIN (President & CEO) has made 0 purchases and 14 sales selling 22,628 shares for an estimated $938,087.
- JONATHAN ZALEVSKY (Chief R&D Officer) has made 0 purchases and 8 sales selling 7,410 shares for an estimated $286,168.
- MARK ANDREW WILSON (Chief Legal Officer) sold 630 shares for an estimated $34,196
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NKTR Hedge Fund Activity
We have seen 102 institutional investors add shares of $NKTR stock to their portfolio, and 95 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FARALLON CAPITAL MANAGEMENT LLC removed 791,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $33,443,480
- TWO SEAS CAPITAL LP added 745,185 shares (+inf%) to their portfolio in Q4 2025, for an estimated $31,506,421
- PROSIGHT MANAGEMENT, LP added 554,633 shares (+inf%) to their portfolio in Q4 2025, for an estimated $23,449,883
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 541,586 shares (-58.6%) from their portfolio in Q4 2025, for an estimated $22,898,256
- AQR CAPITAL MANAGEMENT LLC removed 427,867 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $24,345,632
- MORGAN STANLEY removed 362,730 shares (-39.0%) from their portfolio in Q4 2025, for an estimated $15,336,224
- ARMISTICE CAPITAL, LLC added 328,000 shares (+122.4%) to their portfolio in Q4 2025, for an estimated $13,867,840
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NKTR Revenue
$NKTR had revenues of $11.8M in Q3 2025. This is a decrease of -51.13% from the same period in the prior year.
You can track NKTR financials on Quiver Quantitative's NKTR stock page.
$NKTR Analyst Ratings
Wall Street analysts have issued reports on $NKTR in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 01/29/2026
- Citigroup issued a "Buy" rating on 11/26/2025
- Jefferies issued a "Buy" rating on 11/26/2025
- B. Riley Securities issued a "Buy" rating on 09/23/2025
To track analyst ratings and price targets for $NKTR, check out Quiver Quantitative's $NKTR forecast page.
$NKTR Price Targets
Multiple analysts have issued price targets for $NKTR recently. We have seen 5 analysts offer price targets for $NKTR in the last 6 months, with a median target of $121.0.
Here are some recent targets:
- Arthur He from HC Wainwright & Co. set a target price of $165.0 on 02/10/2026
- Julian Harrison from BTIG set a target price of $151.0 on 02/10/2026
- Samantha Semenkow from Citigroup set a target price of $102.0 on 11/26/2025
- Roger Song from Jefferies set a target price of $121.0 on 11/26/2025
- Mayank Mamtani from B. Riley Securities set a target price of $105.0 on 09/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
